464280.KQ
Price:
$6090
Market Cap:
$32.21B
Established on November 11, 2002, TDS Pharm Co. Ltd. is headquartered in Seongnam-si, South Korea, and specializes in the creation and manufacturing of transdermal drug delivery solutions. Their offerings include items such as cataplasma, plasta, fucidin band, and various prescription pharmaceuticals.
Industry
Drug Manufacturers - General
IPO Date
2024-08-21
Stock Exchange
KOE
Ticker
464280.KQ
According to Tdspharm’s latest financial reports and current stock price. The company's current ROE is 12.06%. This represents a change of 301.01% compared to the average of 3.01% of the last 4 quarters.
The mean historical ROE of Tdspharm over the last ten years is 13.33%. The current 12.06% ROE has changed -9.55% with respect to the historical average. Over the past ten years (40 quarters), 464280.KQ's ROE was at its highest in in the December 2023 quarter at 6.72%. The ROE was at its lowest in in the March 2023 quarter at 0%.
Average
13.33%
Median
11.38%
Minimum
8.27%
Maximum
20.43%
Discovering the peaks and valleys of Tdspharm ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 54.51%
Maximum Annual ROE = 20.43%
Minimum Annual Increase = -52.74%
Minimum Annual ROE = 8.27%
| Year | ROE | Change |
|---|---|---|
| 2025 | 9.99% | 3.47% |
| 2024 | 9.66% | -52.74% |
| 2023 | 20.43% | 8.25% |
| 2022 | 18.87% | 47.70% |
| 2021 | 12.78% | 54.51% |
The current ROE of Tdspharm (464280.KQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
13.36%
5-year avg
14.35%
10-year avg
13.33%
Tdspharm’s ROE is greater than Metacare Co., Ltd. (-1.61%), greater than BCWORLD PHARM. Co., Ltd. (-4.08%), greater than Hass (-0.35%), greater than MYUNGMOON Pharm co.,Ltd (-1.70%), greater than IVIM Technology (-9.90%), less than Yuyu Pharma, Inc. (9.56%), greater than PharmGen Science, Inc. (-78.52%), greater than LAMEDITECH Co., Ltd. (-116.23%), less than Yuyu Pharma, Inc. (9.56%), less than ORIENT BIO Inc. (3.32%),
| Company | ROE | Market cap |
|---|---|---|
| -1.61% | $22.71B | |
| -4.08% | $30.87B | |
| -0.35% | $39.05B | |
| -1.70% | $40.62B | |
| -9.90% | $42.86B | |
| 9.56% | $52.93B | |
| -78.52% | $68.48B | |
| -116.23% | $25.53B | |
| 9.56% | $58.34B | |
| 3.32% | $54.49B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tdspharm using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tdspharm or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Tdspharm's ROE?
How is the ROE calculated for Tdspharm (464280.KQ)?
What is the highest ROE for Tdspharm (464280.KQ)?
What is the 3-year average ROE for Tdspharm (464280.KQ)?
What is the 5-year average ROE for Tdspharm (464280.KQ)?
How does the current ROE for Tdspharm (464280.KQ) compare to its historical average?